‘Long COVID’ – in which people have symptoms lasting more than a few weeks – is turning out to be very common. People hospitalized for COVID-19 are at highest risk, but they aren’t alone.
Rigor acadêmico, estilo jornalístico
Todos os artigos de Long COVID
Exibindo 121 - 125 de 125 artigos
We will have no idea of the full toll of the pandemic unless we account for those who haven’t yet recovered from COVID-19.
Long-lasting symptoms appear unrelated to how bad your infection was, though women appear more affected than men.
Antibodies that go rogue and attack healthy tissue identified in patients with severe COVID.
An overactive immune system may be behind some of the virus’s long after-effects.
Principais colaboradores
-
Professor of Public Health, University of Southampton
-
Associate Professor, Department of Public Health, University of Otago
-
Professor, Research Centre for Hauora and Health, Massey University
-
Research Fellow, Faculty of Health Sciences, Curtin University, and The Perron Institute for Neurological and Translational Science, Curtin University
-
Professor of Public Health, University of Otago
-
Research Fellow, The University of Western Australia
-
Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
-
Conjoint Professor, School of Medicine and Public Health, University of Newcastle
-
Professor of Genomic Epidemiology and Hon Consultant Rheumatologist, King's College London
-
SHARP Professor, Vitalities Lab, Centre for Social Research in Health and Social Policy Centre, and the ARC Centre of Excellence for Automated Decision-Making and Society, UNSW Sydney
-
Associate Professor, Child and Adolescent Health, University of Sydney
-
Associate Professor, Texas A&M University
-
Associate Professor, Division of Infectious Diseases, Department of Medicine, McMaster University
-
Associate Clinical Professor, Institute of Applied Health Research, University of Birmingham
-
Professor of Health Studies, University of Westminster
